semaglutide and wound healing Frontiers GLP-1 Receptor Agonists as Emerging

For some patients, microdosing GLP-1 medications may work to achieve their health goals

What supports Obesity/BMI-qualified patients

Some early data suggested it might actually promote fat storage

Over the entire time period analyzed between May 2022 and September 2023 researchers found that patients taking Mounjaro were three times more likely to lose 15% of their weight than those on Ozempic

In this phase 2 study, 48 patients with obesity or who were overweight and also had alcohol use disorder were randomly assigned either a placebo or a low dose of semaglutide, with researchers testing how much the drug changed drinking habits after about two months